• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.09% Nasdaq Up0.98%

    More On SAMRATPH.BO

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    Samrat Pharmachem Ltd (SAMRATPH.BO)

    -BSE
    35.60 Down 3.60(9.18%) 5:57AM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Mar 31, 2014Mar 31, 2013Mar 31, 2012
    Total Revenue 474,000   653,000   708,000   695,000  
    Cost of Revenue443,000  620,000  671,000  608,000  
    Gross Profit 31,000   33,000   36,000   88,000  
    Operating Expenses
    Research Development -   -   -   -  
    Selling General and Administrative -   -   -   -  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses465,000  645,000  695,000  634,000  
    Operating Income or Loss 9,000   9,000   13,000   62,000  
    Income from Continuing Operations
    Total Other Income/Expenses Net -   -   -   -  
    Earnings Before Interest And Taxes9,000  9,000  13,000  62,000  
    Interest Expense(6,000)(3,000)(3,000)(1,000)
    Income Before Tax -   -   -   -  
    Income Tax Expense2,000  2,000  2,000  20,000  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops3,000  2,000  4,000  38,000  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 3,000   2,000   4,000   38,000  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares -   -   -   -  

    Currency in INR.